NK、T混合淋巴细胞与顺铂以不同时序联合作用于肺癌细胞的体外研究

Effect of combined use of NKTm cells and cisplatin on tumoricidal activity against human pulmonal giant cell carcinoma cells in vitro

  • 摘要: 目的:探讨NK、T混合淋巴细胞(NKTm)与顺铂联合应用于肺巨细胞癌PLA-801D细胞的最佳时序方案,为临床治疗提供实验依据。方法:按加入NK、T混合淋巴细胞(NKTm)和顺铂的时序不同分为7个时序组,每个时序组中设单顺铂组,单NK、T混合淋巴细胞(NKTm)组及联合组,MTT法分别测定各组对PLA-801D细胞的抑制率。结果:各时序组中联合组的抑制率高于单顺铂组和单NK、T混合淋巴细胞(NKTm)组(P<0.01),各时序组联合应用的Q值均大于1.15,且先用NK、T混合淋巴细胞(NKTm)4 h后再用顺铂组的Q值最大(Q=2.297)。结论:体外研究表明,NK、T混合淋巴细胞(NKTm)与顺铂联合应用具有协同效应,先用NK、T混合淋巴细胞(NK-Tm)后4 h再用顺铂为最佳时序方案。

     

    Abstract: Objective: To investigate the best choice of combined treatment to human pulmoal giant cell carcinoma cells(PLA-801D)with mixture of NK and T lymphocytes(NKTm cells)and cisplatin(DDP) in different sequences.Methods: The inhibited rates of PLA-801D cells treated by single NKTm cells,single DDP,and combined treatment of NKTm cells and DDP in different sequences were determined with MTT colorimetric assay.Results: The effect of combined treatment of NKTm cells and DDP excelled the effect of single NKTm cells treatment and single DDP treatment(P<0.01).Values of Q in all the combined group were more than 1.15;among all the group,the sequence of using NKTm cells first,and then 4 h later using DDP had the highest Q value(Q=2.297).Conclusion: Combined treatment of NKTm cells and DDP had synergistic effect to inhibit PLA-801D cells.The best sequence was to using NKTm cells first,and then 4 h later using DDP.

     

/

返回文章
返回